Navigation Links
Radiology advance points way to non-invasive brain-cancer treatment

Glioblastoma Multiforme, GBM, is a brain cancer death sentence.

Of the approximately 12,000 people who are diagnosed with GBM annually in the U.S., half will die within a year, and the rest within 3 years. The only treatments that stretch survival limits are exceptionally invasive surgeries to remove the tumor and radiation treatment with the maximum tolerated dose - all of which leads to......

Full article >>> y cell death, gadolinium atoms must be localized in the nuclei of cancer cells."

Because of the deadly nature of GBM, De Stasio says an alternative is desperately needed to current therapies. De Stasio says it will be a year before it is known whether the treatment works in animal models, and likely another five to ten years before any clinical trials and available treatments would emerg......

Full article >>>
'"/> By John Morgan 01/02/06

Related biology technology :

1. Quintessence Biosciences advances cancer drug
2. Rockwells $1M gift to UWM will support advanced automation research
3. Healthcare slow to adopt genetic advances
4. Nano-diamond film studied at UW could advance telecommunications
5. Doyle says practical politics must advance embryonic stem cell research
6. Madison biotech introduces drug discovery advance
7. FDA approves advanced digital mammography system
8. Wireless advances in Madison, heats up in Waukesha
9. 55 advance in business plan contest
10. Imago microscope leads to Northwestern research advance
11. GE Healthcares CT Scanner advances coronary imaging
Post Your Comments:

(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading ... the Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio ... and clinical trial team. , Using the CONSULT module, patients and physicians can schedule ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
Breaking Biology Technology:
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
Breaking Biology News(10 mins):